It is widely agreed that the view of informed consent found in the regulations and guidelines struggles to keep pace with the ever-advancing enterprise of human subjects research. Over the last 10 years, there have been serious attempts to rethink informed consent so that it conforms to our considered judgments about cases where we are confident valid consent has been given. These arguments are influenced by an argument from Gopal Sreenivasan, which apparently shows that a potential participant's consent to research participation can be perfectly valid even if she fails to understand the risk-benefit profile of the study. I argue that Sreenivasan's argument fails. The set of clinical trials that is supposed to be ethical in the face of this kind of ignorance is empty. However, I argue that his argument is nonetheless instructive in allowing us to identify three important but neglected areas for future conceptual research on informed consent. I close by arguing that research on these identified questions promises to yield a defensible view of consent, lessen the burden of ambiguity on researchers attempting to obtain consent to research participation, and facilitate socially valuable research.
- Informed Consent
- Research Ethics
- Truth Disclosure
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Can informed consent to research be adapted to risk?
- Informed consent to HIV cure research
- Informed consent for functional MRI research on comatose patients following severe brain injury: balancing the social benefits of research against patient autonomy
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
- An adapted instrument to assess informed consent comprehension among youth and parents in rural western Kenya: a validation study
- Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis
- Phase I oncology trials: why the therapeutic misconception will not go away
- Opt-out and consent
- For love and money: the need to rethink benefits in HIV cure studies
- A pilot study to examine research subjects' perception of participating in research in the emergency department